Publication: Adopting a High-Polyphenolic Diet Is Associated with an Improved Glucose Profile: Prospective Analysis within the PREDIMED-Plus Trial
Loading...
Identifiers
ISSN: 2076-3921
Full text access: http://hdl.handle.net/10668/20774
Full text access: http://hdl.handle.net/20.500.13003/18595
SCOPUS: 2-s2.0-85124207720
WOS: 765359900001
Publication date
Advisors
Journal Title
Journal ISSN
Volume Title
Publishers
Abstract
Previous studies suggested that dietary polyphenols could reduce the incidence and complications of type-2 diabetes (T2D); although the evidence is still limited and inconsistent. This work analyzes whether changing to a diet with a higher polyphenolic content is associated with an improved glucose profile. At baseline, and at 1 year of follow-up visits, 5921 participants (mean age 65.0 ± 4.9, 48.2% women) who had overweight/obesity and metabolic syndrome filled out a validated 143-item semi-quantitative food frequency questionnaire (FFQ), from which polyphenol intakes were calculated. Energy-adjusted total polyphenols and subclasses were categorized in tertiles of changes. Linear mixed-effect models with random intercepts (the recruitment centers) were used to assess associations between changes in polyphenol subclasses intake and 1-year plasma glucose or glycosylated hemoglobin (HbA1c) levels. Increments in total polyphenol intake and some classes were inversely associated with better glucose levels and HbA1c after one year of follow-up. These associations were modified when the analyses were run considering diabetes status separately. To our knowledge, this is the first study to assess the relationship between changes in the intake of all polyphenolic groups and T2D-related parameters in a senior population with T2D or at high-risk of developing T2D.
Description
MeSH Terms
DeCS Terms
Bibliographic citation
Tresserra-Rimbau A, Castro-Barquero S, Becerra-Tomás N, Babio N, Martínez-González M, Corella D, et al. Adopting a High-Polyphenolic Diet Is Associated with an Improved Glucose Profile: Prospective Analysis within the PREDIMED-Plus Trial. Antioxidants. 4 feb 2022;11(2).
Collections
IBIMA-Plataforma BIONAND - Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (Andalucía)
IDIBAPS - Instituto de Investigaciones Biomédicas August Pi i Sunyer (Cataluña)
IdisBa - Instituto de Investigación Sanitaria Illes Balears (Baleares)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)
IdISSC - Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (Madrid)
IIS-FJD - Instituto de Investigación Sanitaria Fundación Jiménez Díaz (Madrid)
Load more IDIBAPS - Instituto de Investigaciones Biomédicas August Pi i Sunyer (Cataluña)
IdisBa - Instituto de Investigación Sanitaria Illes Balears (Baleares)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)
IdISSC - Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (Madrid)
IIS-FJD - Instituto de Investigación Sanitaria Fundación Jiménez Díaz (Madrid)





